MedTrace Logo

Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation

NCT05392738 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-07-20

No results posted yet for this study

Summary

New extended depth of focus intraocular lenses (IOLs) are being used in a broader spectrum of patients than trifocal IOLs. The purpose of this study is to evaluate visual improvement after cataract surgery in patients with glaucoma or ocular hypertension undergoing simultaneous cataract surgery with i-Stent implantation with the implantation of a Vivity IOL. Results will be compared with a group of glaucoma or ocular hypertension undergoing isolated cataract surgery with Vivity implantation, as well as with patients with no pathology undergoing cataract surgery and Vivity implantation

Conditions

  • Lenses, Intraocular
  • Glaucoma Filtration Implants

Interventions

DEVICE

I-Stent implantation

I-Stent implantation

Sponsors & Collaborators

  • Clínica Rementería

    lead OTHER

Principal Investigators

  • Beatriz Puerto, MD · Clínica Rementería

Eligibility

Min Age
40 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-20
Primary Completion
2024-06-30
Completion
2024-06-30
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05392738 on ClinicalTrials.gov